What we do Transchem Limited is an Indian company initially focused on mushroom production, now engaged in bulk drug manufacturing and trading of agricultural goods. |
Founded in 1,976 |
Market share Emerging player in niche pharmaceuticals and agricultural goods trading with exports to North America. |
Problem solved Provides quality bulk drugs and agricultural products, serving pharma and agricultural sectors with international supply capabilities. |
Top clients or who we serve Serves pharmaceutical companies and agricultural traders; operates in B2B export markets primarily in the US, Canada, and Mexico. |
Key management Mahesh Rananavre (Whole Time Director), Sarita Maharao (CFO), Neeraja Karandikar (Company Secretary). |
Our journey and innovations Started as mushroom producer, transitioned to pharmaceuticals; commercialized key drugs and entered agricultural trading recently. |
Where we operate Primarily in India with exports to US, Canada, Mexico, and other international markets. |
Top products or what we offer Bulk drugs such as frusemide, fenbendazole; agricultural goods trading added in FY2025. |
Top brands Key products include frusemide, fenbendazole, albendazole, diminazine aceturate, triclabendazole. |
Raw materials needed Pharmaceutical raw chemicals and agricultural commodities. |
Raw materials supplier Not specified in provided data. |
Recurring vs cyclical contribution Revenue includes recurring pharmaceutical supply and trading income, with some cyclicality due to market conditions. |
Our industry position A niche player with growing presence in pharmaceutical bulk drugs and agricultural goods trading sectors. |
Financial highlights FY 2025 revenue Rs. 2.63 Cr; profit Rs. 5.23 Cr indicating operational profitability and growth. |
Geographical revenue split Exports primarily to North America; domestic sales contribute to overall revenue. |
Order book - |
Whats driving growth Expansion into agricultural goods trading and steady growth in pharmaceutical exports drive growth. |
Our future plans Continue diversifying into agricultural goods and explore innovation in pharmaceuticals. |
Our green promise - |
Our people and values Committed workforce with emphasis on compliance, ethics, and sustainable growth. |
Key challenges ahead Market competition, operational revival of dormant divisions, and navigating international trade dynamics. |
Interesting facts Started as an export-oriented mushroom producer; commercialized multiple pharmaceutical products; recently expanded into agriculture trading. |
Risks and strategy Risks include market volatility and non-feasible revival of mushroom business; strategy focuses on pharma exports and agri trading diversification. |
